Literature DB >> 8433818

Fusion after surgical alignment of longstanding strabismus in adults.

R J Morris1, W E Scott, C F Dickey.   

Abstract

BACKGROUND: Fusion and the development of the monofixation syndrome are well recognized after surgical alignment of congenital esotropia to within 8 delta of orthotropia. However, in adults with longstanding strabismus and a history of congenital esotropia who are not surgically aligned within the first few years of life, the prognosis for the development of fusion is believed to be poor. METHODS AND
RESULTS: Twenty-four adults, 12 with a history of congenital esotropia (onset before 6 months age), 1 of congenital exotropia, and 11 with the onset of esotropia between 6 months and 2 years, were included in this study. All patients had longstanding strabismus, and none had been surgically aligned within the first 2 years of life. No patient had visual acuity worse than 20/30 in the worse eye. Preoperatively, no patient demonstrated fusion with the red glass test, Worth four-dot, or Titmus test. Postoperatively, all were aligned to within 8 delta of orthotropia, and all demonstrated peripheral fusion with the Worth four-dot at near. Twelve patients (50%), 8 of whom were in the congenital group, achieved stereopsis of 200 seconds of arc or better using the Titmus stereo test.
CONCLUSION: These findings suggest that surgery in this group of patients not only eliminates the ocular alignment deformity but can confer the functional benefits of fusion and increased field of binocular vision.

Entities:  

Mesh:

Year:  1993        PMID: 8433818     DOI: 10.1016/s0161-6420(93)31703-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

1.  The utility of strabismus in adults.

Authors:  George R Beauchamp; Joost Felius; David R Stager; Cynthia L Beauchamp
Journal:  Trans Am Ophthalmol Soc       Date:  2005

2.  Comparing outcome criteria performance in adult strabismus surgery.

Authors:  Sarah R Hatt; David A Leske; Laura Liebermann; Jonathan M Holmes
Journal:  Ophthalmology       Date:  2012-04-26       Impact factor: 12.079

3.  The decompensated monofixation syndrome (an American Ophthalmological Society thesis).

Authors:  R Michael Siatkowski
Journal:  Trans Am Ophthalmol Soc       Date:  2011-12

4.  Quality of life and cost-utility assessment after strabismus surgery in adults.

Authors:  Keiko Fujiike; Yoshinobu Mizuno; Yoshimune Hiratsuka; Masakazu Yamada
Journal:  Jpn J Ophthalmol       Date:  2011-04-27       Impact factor: 2.447

5.  Adults with Longstanding Strabismus: Psychosocial and Functional Impacts and Reasons behind Surgery Delay.

Authors:  Rami Al-Omari; Hisham M Jammal; Yousef Khader; Dema Atoum; Wedad Al-Dolat; Moawiah Khatatbeh
Journal:  J Ophthalmol       Date:  2022-06-16       Impact factor: 1.974

6.  Binocularity following surgical correction of strabismus in adults.

Authors:  Marilyn B Mets; Cynthia Beauchamp; Betty Anne Haldi
Journal:  Trans Am Ophthalmol Soc       Date:  2003

7.  Fixation stability after surgical treatment of strabismus and biofeedback fixation training in amblyopic eyes.

Authors:  Otto Alexander Maneschg; Mirella Telles Salgueiro Barboni; Zoltán Zsolt Nagy; János Németh
Journal:  BMC Ophthalmol       Date:  2021-06-24       Impact factor: 2.209

8.  Sensory eye balance in surgically corrected intermittent exotropes with normal stereopsis.

Authors:  Lixia Feng; Jiawei Zhou; Li Chen; Robert F Hess
Journal:  Sci Rep       Date:  2015-08-19       Impact factor: 4.379

9.  To evaluate stereoacuity in patients with acquired esotropia and to determine factors associated with favourable outcomes.

Authors:  Monisha E Nongpiur; Anirudh Singh; Rohit Saxena; Anudeepa Sharma; Pradeep Sharma
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

10.  Long-term Surgical Outcomes of Initial Postoperative Overcorrection in Adults with Intermittent Exotropia.

Authors:  Jong Ho Ahn; Haejung Paik
Journal:  Korean J Ophthalmol       Date:  2018-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.